Dr. Pessin is a experienced Clinical Pathologist with additional board certification in Transfusion Medicine and Clinical Informatics. Her current interests are in pathology informatics, optimization of laboratory test utilization and new test methodologies.
Memorial Sloan Kettering Cancer Center
New York, NY
- Physician Executive Development Program
2019
College of Physicians & Surgeons of Columbia University
New York, NY
- Clinical Pathology
1995
The Rockefeller University
New York, NY
- Postdoctoral Fellow, Greengard Laboratory
1992
The Johns Hopkins University School of Medicine
Baltimore, MD
MD - Medicine
1991
The Johns Hopkins University School of Medicine
Baltimore, MD
PhD - Neuroscience
1991
Princeton University
Princeton, NJ
BS - Electrical Engineering & Computer Science
1984
Ellinor Peerschke, PhD (1954-2023).
Ellinor Peerschke, PhD (1954-2023). J Thromb Haemost. 2024 Mar; 22(3):889-891.
PMID: 38104722
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting. J Mol Diagn. 2022 08; 24(8):867-877.
PMID: 35934321
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer.
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer. JAMA Oncol. 2021 11 01; 7(11):1686-1691.
PMID: 34410305
Clonal hematopoiesis is associated with risk of severe Covid-19.
Clonal hematopoiesis is associated with risk of severe Covid-19. Nat Commun. 2021 10 13; 12(1):5975.
PMID: 34645798
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy. Blood Cancer Discov. 2021 11; 2(6):577-585.
PMID: 34778798
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies.
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies. Blood Cancer Discov. 2021 11; 2(6):568-576.
PMID: 34778797
Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy. Cancer Immunol Immunother. 2021 Aug; 70(8):2415.
PMID: 33929584
The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic.
The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic. Acad Pathol. 2021 Jan-Dec; 8:23742895211006818.
PMID: 34013020
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy. Cancer Immunol Immunother. 2021 Aug; 70(8):2411-2414.
PMID: 33533945
Clonal hematopoiesis is associated with risk of severe Covid-19.
Clonal hematopoiesis is associated with risk of severe Covid-19. medRxiv. 2020 Nov 27.
PMID: 33269365
The Pathologist's Power List 2018
The Pathologist
2018